... randomized, double-blind, placebo-controlled Phase 2 trial indicated a statistically significant ... safe and well-tolerated. Full results from this Phase 2 trial are planned to be presented at a future ...
... apparent potential and limited side effects, a multi-center, phase-2, placebo-controlled, cross-over study is being organized. It will likely enroll patients with stable disease on pre- ...
... immune system to attack tumors, were combined for the first time in this phase 2 clinical trial.
“With each new study, we learn something important about melanoma,” said John M. Kirkwood, ...
... outcomes in patients with diabetes. The researchers identified phase 2 through 4 RCTs enrolling ... trial duration while trials of patients with type 2 diabetes were significantly less likely to report ...
... HIF1 inhibitor. "We are actively pursuing this clinically and will be moving this study into Phase 2," Dewhirst said. "We are interested in other applications of HIF-1 inhibition in combination with ...
... over an age 70 years and who will be treated within 2.5 hours or less.
Some 841 patients in 73 ... of outcome and mortality
Three years ago, a phase-2 study with recombinant coagulation factor VIIa ...
... the Lancet. The patch-based vaccine is part of the Phase 2 study in conjunction with the Iomai Corporation. ... either two doses of the vaccine patch or a placebo, 2 to 3 weeks apart, with the last dose ...
... to suffer from clinically significant diarrhea than those who received placebo, according to a new study. The patch-based vaccine is part of the Phase 2 study in conjunction with the Iomai Corp.
... to plant-grown antibodies, Levy said.
The next research step is a phase-2 clinical trial to test the effectiveness of plant-grown vaccines in a larger group of lymphoma patients, Levy ...
... survival rate. Dr. Kenneth Chang of University of California Irvine Medical Center and his colleagues conducted a Phase 2 multi-center study on the safety and long-term efficacy ...
... drug interferon beta-1a. However, as the study was a Phase 2 clinical trial, additional research will ... complication can be easily treated if recognised early.
The Phase 2 clinical study involved 334 ...
... to months to show up. It can be prohibitively expensive to conduct phase 2 or phase 3 trials of medications long enough to detect the changes in FEV1.
National Jewish researchers thought ...
... said, and the child's treatment was tailored to reflect the findings from the animal study.
A phase 2 clinical trial of this treatment in people with neurofibromatosis has been approved and is under ...
... myelogenous leukemia and other cancers, the researchers were able to secure fast regulatory approval for a phase 2 clinical trial of the drug in children and adults with neurofibromatosis type 1.
In ...
... Since PROPEL has been given fast-track status, the company will submit pralatrexate for FDA approval once the Phase 2 data has been finalized -- sometime in the first half of 2009. ...
